Evidence map›Paper›PMID 41884059›Full record

ArticleJHLT open2026

Tomoaki Yoshitake, Takeo Fujino, Toru Hashimoto, Shoei Yamamoto, Kei Ikuta, Tomoyasu Suenaga, Kayo Misumi, Keisuke Shinohara, Shouji Matsushima, Yoshiyuki Kitamura and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Non-invasive imaging in heart transplant recipients: state of art and future direction.European journal of nuclear medicine and molecular imaging · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Tomoaki YoshitakeDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takeo FujinoDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Toru HashimotoDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shoei YamamotoDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kei IkutaDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tomoyasu SuenagaDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kayo MisumiDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Keisuke ShinoharaDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shouji MatsushimaDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yoshiyuki KitamuraDepartment of Clinical Radiology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takuro IsodaDepartment of Clinical Radiology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shingo BabaDepartment of Health Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shintaro KinugawaDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kousei IshigamiDepartment of Clinical Radiology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Akira ShioseDepartment of Cardiovascular Surgery, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kohtaro AbeDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although histopathological evaluation of myocardium is essential for detecting both acute cellular rejection (ACR) and antibody-mediated rejection (AMR) following heart transplantation, indeterminate results and complication risks associated with repeated endomyocardial biopsies remain serious problems. We investigated the clinical utility of Methods: This retrospective single-center study reviewed the clinical data of heart-transplant recipients at our institution between 2008 and 2022. Patients who underwent Results: During the study period, 132 Conclusions: FDG uptake was significantly elevated at the time of ACR.

Indexed as

18F-FDG PET/CTacute cellular rejectionheart failureheart transplantationrejection

Identifiers

PMID41884059
PMCPMC13010973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.